Patent Issued for Intragastric device (USPTO 11974934).

ReShape Lifesciences Inc. has been granted a patent for an intragastric device that aims to reduce weight by occupying space in the stomach, leading to a feeling of fullness and a decrease in caloric intake. The patent discusses the limitations of current weight control methods and highlights obesity as a significant health issue. The intragastric balloon system described in the patent involves a swallowable capsule containing a balloon that can be inflated with a chosen gas or gas mixture. The inventors provide specific claims about the design and functionality of the system, as well as techniques for manufacturing and packaging the device for easy swallowing. [Extracted from the article]